Currently Viewing:
Newsroom

Most Read News (So Far) of 2017

Laura Joszt
With the year 2017 halfway over, The American Journal of Managed Care® is looking back at the news of the first half of the year. Here we bring you the most read news stories, including conference coverage, a take on the new president’s first executive order, reimbursement challenges, and more.
With the year 2017 halfway over, The American Journal of Managed Care® is looking back at the news of the first half of the year. Here we bring you the most read news stories, including conference coverage, a take on the new president’s first executive order, reimbursement challenges, and more.
 
10. FTC Remains Doubtful About Walgreens' Acquisition of Rite Aid
From the very beginning, the proposed Walgreens and Rite Aid merger faced intense scrutiny. As part of the deal, Walgreens would buy Rite Aid for more than $17.2 billion, giving Walgreens control over more than 12,700 stores nationwide. This would also give Walgreens a near monopoly—CVS would be in a distant second with just 7800 stores.
 
On June 29, Walgreens decided to scrap its plans to merge with Rite Aid, and instead chose to purchase nearly half of Rite Aid’s stores for $5 billion.
 
Read more.
 
9. Heart Risks at Midlife Signal Dementia Down the Road
A study presented at the International Stroke Conference added to the growing body of evidence linking heart disease and diabetes to dementia. The study followed nearly 16,000 people in the US and found the risk of developing the cognitive disorder later in life was 77% higher for people with diabetes, 41% higher among those who smoked at midlife, 39% higher in people with high blood pressure, and 31% higher in people with prehypertension.
 
Read more.
 
8. What Does Trump's Executive Order Mean for Diabetes Prevention?
The first thing President Donald J. Trump did after being inaugurated was sign an executive order to ease the regulatory burdens of the Affordable Care Act (ACA). However, people in the diabetes community were concerned about what the order meant for the National Diabetes Prevention Program, which is set to launch on January 1, 2018. The program took advantage of the ACA’s waiver process to provide federal dollars for a program that aimed to prevent diabetes in a group of Americans who already had prediabetes.
 
Read more.
 
7. Driving Value With Innovative Approaches to Colon Cancer Screening
This article from AJMC.com contributor Jim Thomson, the chief operating officer at Physicians Plus Insurance Corporation, took a look at screening recommendations for colorectal cancer (CRC). He noted that compliance for CRC screening is merely 38%, even though there is clear benefit to being screened. However, despite being a valuable tool, the fact that people avoid CRC screening because they don’t want to get a colonoscopy undermines the value of it.
 
Read more.
 
6. Trial Results Published for Medtronic's MiniMed 670G
The MiniMed670G from Medtronic was the first “artificial pancreas” approved by the FDA. A pivotal trial for the device found that the hybrid closed-loop insulin delivery system was safe for home use, reduced glycated hemoglobin and hypoglycemia or hyperglycemia compared with where patients were at baseline.
 
Read more.
 


 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up